Recombinant Human IGFBP5 (E. coli)
Cat. No. | Z102015 |
Name | Recombinant Human IGFBP5 (E. coli) |
Description | An IGF-binding protein, IBP-5 is produced by fibroblasts, myoblasts, osteoblasts and vascular smooth muscle cells. IBP-5 has been shown to specifically inhibit breast cancer cell growth by inducing apoptosis. IBP-5 contains an IGFBP domain and a thyroglobulin type-1 domain. |
Organism | Human (H. sapiens) |
Unit quantity | 25 µg |
Family | IGF/Insulin Family |
Aliases | IBP5 |
Gene Symbol | IGFBP5 |
Gene ID | 3488 |
Accession Number | P24593 |
Source | E. coli |
Species | Human (H. sapiens) |
Appearance | Lyophilized Powder |
Molecular Weight | 26.5 kDa |
Endotoxin Level | <1.0 EU/µg of recombinant protein as determined by the LAL method. |
Purity | >95% as determined by SDS-PAGE |
Formulation | Lyophilized from a 0.2 µm filtered solution of 10mM sodium Citrate pH 3.0 |
Function | N.A. |
Reconstitution | A quick spin of the vial followed by reconstitution in sterile distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers. |
Storage | The lyophilized protein is stable for at least one year from date of receipt at -70°C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8°C for one month, or at -20°C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. |
Usage | For research use only. Not for diagnostic or therapeutic use. |
Material Citation | If use of this material results in a scientific publication, please cite the material in the following manner: Applied Biological Materials Inc, Cat. No. Z102015 |
Print & Download Datasheet
There are no FAQs for this product yet!
There are no references for this product yet!
This product has no review yet.
Controls and Related Product: